Selectis Health Announces Board and Officer Changes
Ticker: GBCS · Form: 8-K · Filed: Jan 23, 2025 · CIK: 727346
| Field | Detail |
|---|---|
| Company | Selectis Health, Inc. (GBCS) |
| Form Type | 8-K |
| Filed Date | Jan 23, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update
Related Tickers: SLCT
TL;DR
SELECTIS HEALTH (SLCT) REFILES 8-K WITH BOARD/OFFICER CHANGES AND FINANCIALS.
AI Summary
Selectis Health, Inc. announced on January 17, 2025, changes in its board and officer appointments. The company also filed financial statements and exhibits related to these events. This filing follows a period of corporate name changes, with the company previously known as Global Healthcare REIT, Inc. and Global Casinos Inc.
Why It Matters
Changes in board composition and officer appointments can signal shifts in company strategy, leadership, and future direction.
Risk Assessment
Risk Level: low — The filing is a routine 8-K reporting changes in directors and officers, not a material financial event.
Key Players & Entities
- SELECTIS HEALTH, INC. (company) — Registrant
- GLOBAL HEALTHCARE REIT, INC. (company) — Former Company Name
- GLOBAL CASINOS INC (company) — Former Company Name
- MORGRO CHEMICAL CO (company) — Former Company Name
- January 17, 2025 (date) — Date of earliest event reported
FAQ
What specific changes were made to the board of directors or officers?
The filing indicates "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers" but does not detail the specific individuals or roles affected in the provided text.
What is the significance of the financial statements and exhibits being filed?
The financial statements and exhibits are filed in conjunction with the reported changes in directors and officers, likely to provide supporting documentation or context for these corporate actions.
When was the company previously known as Global Healthcare REIT, Inc.?
The company's name was changed from Global Healthcare REIT, Inc. on October 4, 2013.
What is Selectis Health, Inc.'s state of incorporation and IRS number?
Selectis Health, Inc. is incorporated in Utah and has an IRS number of 87-0340206.
What is the SIC code for Selectis Health, Inc.?
The Standard Industrial Classification (SIC) code for Selectis Health, Inc. is 6798, which corresponds to Real Estate Investment Trusts.
Filing Stats: 395 words · 2 min read · ~1 pages · Grade level 11.9 · Accepted 2025-01-23 13:08:31
Filing Documents
- form8-k.htm (8-K) — 33KB
- ex10-1.htm (EX-10.1) — 5KB
- ex10-1_001.jpg (GRAPHIC) — 559KB
- ex10-1_002.jpg (GRAPHIC) — 573KB
- ex10-1_003.jpg (GRAPHIC) — 693KB
- ex10-1_004.jpg (GRAPHIC) — 698KB
- ex10-1_005.jpg (GRAPHIC) — 503KB
- ex10-1_006.jpg (GRAPHIC) — 34KB
- 0001493152-25-003346.txt ( ) — 4419KB
- gbcs-20250117.xsd (EX-101.SCH) — 3KB
- gbcs-20250117_lab.xml (EX-101.LAB) — 33KB
- gbcs-20250117_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
From the Filing
UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2025 SELECTIS HEALTH, INC . (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Number (I.R.S. Employer Identification number) 8480 E. Orchard Road , Ste. 4900 , Greenwood Village , CO 80111 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (720) 680-0808 (Former name or former address, if changed since last report) Written communications pursuant to Rule 425 under the Securities Act Soliciting material pursuant to Rule 14a-12 under the Exchange Act Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act Securities registered pursuant to Section 12(b) of the Act: Title of each Class Trading Symbol Name of each exchange on which registered N/A N/A N/A Indicate by check mark whether the registrant is an emerging growth company as dened in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised nancial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.02 DEPARTURE OF EXECUTIVE OFFICER AND DIRECTOR; APPOINTMENT OF EXECUTIVE OFFICER On January 17, 2025, James Creamer tendered his resignation as Chief Financial Officer of Selectis Health, Inc. (the "Company"), pursuant to a Separation Agreement and Release of even date. Adam Desmond, the Company's current CEO, will serve as the Interim CFO until a permanent CFO is identified. A copy of the Separation Agreement and Release is filed herewith as Exhibit 10.1. ITEM 9.01 FINANCIAL Exhibit 10.1 Separation Agreement and Release 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Selectis Health, Inc. (Registrant) Dated: January 23, 2025 /s/ Adam Desmond Adam Desmond, CEO